KR20090010140A - 흡입용 캡슐 - Google Patents
흡입용 캡슐 Download PDFInfo
- Publication number
- KR20090010140A KR20090010140A KR1020097000835A KR20097000835A KR20090010140A KR 20090010140 A KR20090010140 A KR 20090010140A KR 1020097000835 A KR1020097000835 A KR 1020097000835A KR 20097000835 A KR20097000835 A KR 20097000835A KR 20090010140 A KR20090010140 A KR 20090010140A
- Authority
- KR
- South Korea
- Prior art keywords
- capsule
- moisture content
- inhalation
- excipient
- tiotropium
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
- A61M11/003—Particle size control by passing the aerosol trough sieves or filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
파수(cm-1) | 귀인(attribution) | 진동 유형 |
3570, 410 | O-H | 연장된 진동(elongated oscillation) |
3105 | 아릴 C-H | 연장된 진동 |
1730 | C=O | 연장된 진동 |
1260 | 에폭사이드 C-O | 연장된 진동 |
1035 | 에스테르 C-OC | 연장된 진동 |
720 | 티오펜 | 환형 진동(cyclic oscillation) |
Claims (13)
- 흡입 가능한 분말로서 생리학적으로 허용되는 부형제와 혼합된 티오트로피움을 함유하고, 캡슐 재료가 셀룰로스 유도체, 전분, 전분 유도체, 키토산 및 합성 플라스틱으로부터 선택되며, 캡슐 재료의 TEWS 수분 함량 또는 할로겐 건조기 수분 함량이 15% 미만임을 특징으로 하는 흡입용 캡슐.
- 제1항에 있어서, 캡슐 재료가, 셀룰로스 유도체인 하이드록시프로필메틸셀룰로스, 하이드록시프로필셀룰로스, 메틸셀룰로스, 하이드록시메틸셀룰로스 및 하이드록시에틸셀룰로스로부터 선택됨을 특징으로 하는 흡입용 캡슐.
- 제2항에 있어서, 캡슐 재료가, TEWS 수분 함량 또는 할로겐 건조기 수분 함량이 8% 미만임을 특징으로 하는 흡입용 캡슐.
- 제1항에 있어서, 캡슐 재료가, 합성 플라스틱인 폴리에틸렌, 폴리카보네이트, 폴리에스테르, 폴리프로필렌 및 폴리에틸렌 테레프탈레이트로부터 선택됨을 특징으로 하는 흡입용 캡슐.
- 제4항에 있어서, 캡슐 재료가, 폴리에틸렌, 폴리카보네이트 및 폴리에틸렌 테레프탈레이트로부터 선택됨을 특징으로 하는 흡입용 캡슐.
- 제4항에 있어서, 캡슐 재료가, TEWS 수분 함량 또는 할로겐 건조기 수분 함량이 3% 미만임을 특징으로 하는 흡입용 캡슐.
- 제1항 내지 제6항 중의 어느 한 항에 있어서, 흡입 가능한 분말이 생리학적으로 허용되는 부형제와 혼합된 티오트로피움을 0.001 내지 2 중량% 함유함을 특징으로 하는 흡입용 캡슐.
- 제7항에 있어서, 부형제가 평균 입자 크기가 15 내지 80㎛인 조악한 부형제와 평균 입자 크기가 1 내지 9㎛인 미세한 부형제와의 혼합물로 이루어지고, 전체량의 부형제 중의 미세한 부형제의 비율이 1 내지 20 중량% 임을 특징으로 하는 흡입용 캡슐.
- 제8항에 있어서, 티오트로피움이, 클로라이드, 브로마이드, 요오다이드, 메탄설포네이트, p-톨루엔설포네이트 또는 메틸설페이트 형태로 존재함을 특징으로 하는 흡입용 캡슐.
- 제1항 내지 제6항 중의 어느 한 항에 있어서, 흡입 가능한 분말을 투여하기에 적합한 흡입기에 사용하기 위한 흡입용 캡슐.
- 제1항 내지 제6항 중의 어느 한 항에 따르는 티오트로피움을 함유하는 흡입용 캡슐을 제조하기 위한, TEWS 수분 함량 또는 할로겐 건조기 수분 함량이 15% 미만이고 캡슐 재료가 셀룰로스 유도체, 전분, 전분 유도체, 키토산 및 합성 플라스틱으로부터 선택됨을 특징으로 하는 빈 캡슐.
- 제3항에 있어서, 캡슐 재료가, TEWS 수분 함량 또는 할로겐 건조기 수분 함량이 5% 이하임을 특징으로 하는 흡입용 캡슐.
- 제6항에 있어서, 캡슐 재료가, TEWS 수분 함량 또는 할로겐 건조기 수분 함량이 1% 이하임을 특징으로 하는 흡입용 캡슐.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10126924.2 | 2001-06-01 | ||
DE10126924A DE10126924A1 (de) | 2001-06-01 | 2001-06-01 | Inhalationskapseln |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037015718A Division KR100921904B1 (ko) | 2001-06-01 | 2002-05-27 | 흡입용 캡슐 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090010140A true KR20090010140A (ko) | 2009-01-28 |
KR100952321B1 KR100952321B1 (ko) | 2010-04-09 |
Family
ID=7687020
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037015718A KR100921904B1 (ko) | 2001-06-01 | 2002-05-27 | 흡입용 캡슐 |
KR1020097000835A KR100952321B1 (ko) | 2001-06-01 | 2002-05-27 | 흡입용 캡슐 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037015718A KR100921904B1 (ko) | 2001-06-01 | 2002-05-27 | 흡입용 캡슐 |
Country Status (37)
Country | Link |
---|---|
EP (2) | EP1379220B1 (ko) |
JP (3) | JP4447311B2 (ko) |
KR (2) | KR100921904B1 (ko) |
CN (3) | CN101829072A (ko) |
AR (2) | AR034346A1 (ko) |
AT (1) | ATE285752T1 (ko) |
AU (2) | AU2002344354B2 (ko) |
BG (1) | BG65655B1 (ko) |
BR (1) | BR0209366A (ko) |
CA (1) | CA2448425C (ko) |
CH (1) | CH1379220H1 (ko) |
CO (1) | CO5540379A2 (ko) |
CZ (1) | CZ300284B6 (ko) |
DE (2) | DE10126924A1 (ko) |
EA (1) | EA005188B1 (ko) |
EC (2) | ECSP034868A (ko) |
EE (1) | EE05416B1 (ko) |
EG (1) | EG24227A (ko) |
ES (1) | ES2236590B5 (ko) |
HR (1) | HRP20030993B1 (ko) |
HU (3) | HU230058B1 (ko) |
IL (2) | IL158917A0 (ko) |
ME (1) | ME00301B (ko) |
MX (1) | MXPA03010990A (ko) |
MY (1) | MY126253A (ko) |
NO (1) | NO332857B3 (ko) |
NZ (1) | NZ530356A (ko) |
PE (1) | PE20030071A1 (ko) |
PL (2) | PL203801B1 (ko) |
PT (1) | PT1379220E (ko) |
RS (1) | RS50353B (ko) |
SI (1) | SI1379220T1 (ko) |
SK (2) | SK287379B6 (ko) |
TW (1) | TWI327921B (ko) |
UA (1) | UA75659C2 (ko) |
WO (1) | WO2002098874A2 (ko) |
ZA (1) | ZA200308340B (ko) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1210017C (zh) | 2000-10-12 | 2005-07-13 | 贝林格尔英格海姆法玛两合公司 | 含噻托品鎓的新颖可吸入粉末 |
DE10126924A1 (de) * | 2001-06-01 | 2002-12-05 | Boehringer Ingelheim Pharma | Inhalationskapseln |
DE10212264A1 (de) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
JP2005530765A (ja) * | 2002-05-07 | 2005-10-13 | ネクター セラピューティクス | 乾燥粉末吸入器のためのカプセル及びそれを製造及び使用する方法 |
DE10255387A1 (de) * | 2002-11-28 | 2004-06-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Tiotropium-haltige Pulverformulierung für die Inhalation |
US7763280B2 (en) | 2002-11-28 | 2010-07-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing powder formulation for inhalation |
DE10258360A1 (de) * | 2002-12-12 | 2004-06-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverinhalator mit Kapselkammer zum Aufnehmen einer mit Wirkstoff gefüllten Einwegkapsel |
DE10352277A1 (de) * | 2003-11-08 | 2005-06-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverinhalator |
SE0303570L (sv) | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
SE0303269L (sv) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Medicinsk produkt |
GB0503738D0 (en) | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
US7694676B2 (en) | 2005-04-22 | 2010-04-13 | Boehringer Ingelheim Gmbh | Dry powder inhaler |
JP4825455B2 (ja) * | 2005-05-02 | 2011-11-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 粉末吸入器 |
DE102006016901A1 (de) | 2006-04-11 | 2007-10-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Mundstück für einen Inhalator |
DE102006016904A1 (de) | 2006-04-11 | 2007-10-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalator |
GB0716026D0 (en) * | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
DE102007036411A1 (de) | 2007-07-20 | 2009-02-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverinhalator |
DE102007052871A1 (de) * | 2007-11-02 | 2009-05-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Kapsel zur Aufnahme von pharmazeutischen Wirkstoffformulierungen |
US20100327476A1 (en) * | 2008-02-08 | 2010-12-30 | Boehringer Ingelheim International Gmbh | Method and device for filling capsules |
EP2172190A1 (en) * | 2008-10-02 | 2010-04-07 | Laboratorios Liconsa, S.A. | Inhalable particles comprising tiotropium |
EP3578169A1 (en) | 2009-02-26 | 2019-12-11 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
EP2411008B1 (en) * | 2009-03-27 | 2017-03-22 | Mahmut Bilgic | Complexes of tiotropium with improved properties of solubility and stability |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
WO2011152804A2 (en) | 2010-06-03 | 2011-12-08 | Mahmut Bilgic | Process for dry powder formulations |
DE202011102694U1 (de) | 2011-06-29 | 2011-12-19 | Zisser Gmbh | Inhalationsgerät für Heimanwender |
GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
WO2014007768A1 (en) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhaler compositions comprising long acting muscorinic antagonists |
DE202013000774U1 (de) | 2013-01-21 | 2013-04-15 | Rhinofilt GmbH | Miniaturisiertes Inhalationsgerät zur Privatanwendung |
US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
CN108295042A (zh) * | 2018-03-05 | 2018-07-20 | 上海祺宇生物科技有限公司 | 一种用于吸入药剂的植物空心胶囊及其胶囊剂 |
CN108451920A (zh) * | 2018-03-14 | 2018-08-28 | 绍兴康可胶囊有限公司 | 一种吸雾式胶囊及其制备方法 |
CN114848605B (zh) * | 2022-03-25 | 2023-08-11 | 上海方予健康医药科技有限公司 | 一种供吸入粉雾剂用的明胶胶囊 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3931041C2 (de) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
KR100208979B1 (ko) * | 1992-06-12 | 1999-07-15 | 야스이 쇼사꾸 | 기도내 투여용 제제 |
US6228394B1 (en) * | 1997-10-14 | 2001-05-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Supercritical fluid extraction of mould lubricant from hard shell capsules |
DE19835346A1 (de) * | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren |
JP2000143502A (ja) * | 1998-11-11 | 2000-05-23 | Shionogi Qualicaps Kk | 吸入製剤 |
PT1283036E (pt) * | 1998-11-13 | 2008-03-06 | Jagotec Ag | Inalador de pó seco de dose múltipla com um reservatório de pó |
DE19921693A1 (de) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
EP1072258A1 (de) * | 1999-07-28 | 2001-01-31 | Greither, Peter | Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung |
EP1238661A1 (en) * | 1999-10-12 | 2002-09-11 | Kaken Pharmaceutical Co., Ltd. | Powdery inhalational preparations and process for producing the same |
DE10126924A1 (de) * | 2001-06-01 | 2002-12-05 | Boehringer Ingelheim Pharma | Inhalationskapseln |
-
2001
- 2001-06-01 DE DE10126924A patent/DE10126924A1/de not_active Withdrawn
-
2002
- 2002-05-27 CN CN201010143914A patent/CN101829072A/zh active Pending
- 2002-05-27 HU HU0400666A patent/HU230058B1/hu not_active IP Right Cessation
- 2002-05-27 PL PL364108A patent/PL203801B1/pl unknown
- 2002-05-27 PL PL387118A patent/PL205714B1/pl unknown
- 2002-05-27 CA CA2448425A patent/CA2448425C/en not_active Expired - Fee Related
- 2002-05-27 NZ NZ530356A patent/NZ530356A/en not_active IP Right Cessation
- 2002-05-27 CZ CZ20033579A patent/CZ300284B6/cs not_active IP Right Cessation
- 2002-05-27 ES ES02776507.2T patent/ES2236590B5/es not_active Expired - Lifetime
- 2002-05-27 ME MEP-2008-425A patent/ME00301B/me unknown
- 2002-05-27 SK SK1620-2003A patent/SK287379B6/sk not_active IP Right Cessation
- 2002-05-27 IL IL15891702A patent/IL158917A0/xx unknown
- 2002-05-27 DE DE50201898T patent/DE50201898D1/de not_active Expired - Lifetime
- 2002-05-27 KR KR1020037015718A patent/KR100921904B1/ko active IP Right Grant
- 2002-05-27 SK SK50049-2009A patent/SK287346B6/sk not_active IP Right Cessation
- 2002-05-27 CH CH02776507T patent/CH1379220H1/de unknown
- 2002-05-27 KR KR1020097000835A patent/KR100952321B1/ko active IP Right Review Request
- 2002-05-27 MX MXPA03010990A patent/MXPA03010990A/es active IP Right Grant
- 2002-05-27 BR BR0209366-9A patent/BR0209366A/pt active Pending
- 2002-05-27 HU HU1500188A patent/HU230827B1/hu unknown
- 2002-05-27 AT AT02776507T patent/ATE285752T1/de active
- 2002-05-27 PT PT02776507T patent/PT1379220E/pt unknown
- 2002-05-27 SI SI200230077T patent/SI1379220T1/xx unknown
- 2002-05-27 WO PCT/EP2002/005600 patent/WO2002098874A2/de active Application Filing
- 2002-05-27 RS YUP-935/03A patent/RS50353B/sr unknown
- 2002-05-27 EA EA200301275A patent/EA005188B1/ru not_active IP Right Cessation
- 2002-05-27 JP JP2003501995A patent/JP4447311B2/ja not_active Expired - Lifetime
- 2002-05-27 AU AU2002344354A patent/AU2002344354B2/en not_active Expired
- 2002-05-27 EP EP02776507A patent/EP1379220B1/de not_active Expired - Lifetime
- 2002-05-27 UA UA20031212504A patent/UA75659C2/uk unknown
- 2002-05-27 HU HU1800092A patent/HU231082B1/hu unknown
- 2002-05-27 CN CNA028109791A patent/CN1512875A/zh active Pending
- 2002-05-27 CN CN200910149591A patent/CN101697965A/zh active Pending
- 2002-05-27 EE EEP200300595A patent/EE05416B1/xx unknown
- 2002-05-27 EP EP04026411A patent/EP1508330A1/de not_active Withdrawn
- 2002-05-29 AR ARP020102000A patent/AR034346A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
- 2002-05-29 EG EG20020570A patent/EG24227A/xx active
- 2002-05-31 MY MYPI20022036A patent/MY126253A/en unknown
- 2002-05-31 PE PE2002000465A patent/PE20030071A1/es active IP Right Grant
- 2002-05-31 TW TW091111706A patent/TWI327921B/zh not_active IP Right Cessation
-
2003
- 2003-10-27 ZA ZA200308340A patent/ZA200308340B/xx unknown
- 2003-11-18 IL IL158917A patent/IL158917A/en active IP Right Grant
- 2003-11-24 BG BG108380A patent/BG65655B1/bg active Active
- 2003-11-27 EC EC2003004868A patent/ECSP034868A/es unknown
- 2003-11-27 NO NO20035265A patent/NO332857B3/no not_active IP Right Cessation
- 2003-11-28 HR HR20030993A patent/HRP20030993B1/xx not_active IP Right Cessation
- 2003-12-10 CO CO03108303A patent/CO5540379A2/es not_active Application Discontinuation
-
2006
- 2006-02-15 JP JP2006038063A patent/JP4787034B2/ja not_active Expired - Lifetime
-
2007
- 2007-10-03 JP JP2007260177A patent/JP2008050364A/ja active Pending
-
2008
- 2008-07-10 AU AU2008203057A patent/AU2008203057C1/en not_active Expired
-
2011
- 2011-01-06 EC EC2011004868A patent/ECSP11004868A/es unknown
-
2012
- 2012-01-06 AR ARP120100053A patent/AR084804A2/es active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100921904B1 (ko) | 흡입용 캡슐 | |
US20090137621A1 (en) | Capsules Containing Inhalable Tiotropium | |
KR100488644B1 (ko) | 티오트로퓸을 함유하는 신규 흡입용 산제 | |
RU2417224C2 (ru) | Новые кристаллические формы тиотропийбромида | |
AU2003288226B2 (en) | Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate | |
NZ536219A (en) | Inhalation kit comprising inhalable powder of tiotropium | |
CA2531832C (en) | Powdery formulations for inhalation, containing a novel anticholinergic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130329 Year of fee payment: 4 |
|
J204 | Request for invalidation trial [patent] | ||
FPAY | Annual fee payment |
Payment date: 20160328 Year of fee payment: 7 |
|
J301 | Trial decision |
Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20140924 Effective date: 20160523 |
|
J2X1 | Appeal (before the patent court) |
Free format text: INVALIDATION |
|
FPAY | Annual fee payment |
Payment date: 20170324 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180323 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190329 Year of fee payment: 10 |
|
J302 | Written judgement (patent court) |
Free format text: TRIAL NUMBER: 2016200005613; JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20160722 Effective date: 20180131 |
|
J303 | Written judgement (supreme court) |
Free format text: TRIAL NUMBER: 2018300010664; JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20180322 Effective date: 20190314 |
|
G170 | Re-publication after modification of scope of protection [patent] |